XTL BIOPHARMACEUTICALS LTD. Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2024-12-30: Form 6-K; Period of report 2024-12-30; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea022610402-6k_xtlbio.htm.
- 2024-12-30: Form 6-K; Period of report 2024-12-30; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea022610401-6k_xtlbio.htm.
- 2024-11-19: Form 6-K; Period of report 2024-11-19; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea0221906-6k_xtlbio.htm.
- 2024-11-12: Form 6-K; Period of report 2024-11-12; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea0220818-6k_xtlbio.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2024-12-30 | 6-K | 2024-12-30 | REPORT OF FOREIGN PRIVATE ISSUER | ea022610402-6k_xtlbio.htm |
| 2024-12-30 | 6-K | 2024-12-30 | REPORT OF FOREIGN PRIVATE ISSUER | ea022610401-6k_xtlbio.htm |
| 2024-11-19 | 6-K | 2024-11-19 | REPORT OF FOREIGN PRIVATE ISSUER | ea0221906-6k_xtlbio.htm |
| 2024-11-12 | 6-K | 2024-11-12 | REPORT OF FOREIGN PRIVATE ISSUER | ea0220818-6k_xtlbio.htm |
| 2024-10-15 | 6-K | 2024-10-15 | REPORT OF FOREIGN PRIVATE ISSUER | ea0217533-6k_xtlbio.htm |
| 2024-08-14 | 6-K | 2024-08-14 | REPORT OF FOREIGN PRIVATE ISSUER | ea0211391-6k_xtlbio.htm |
| 2024-07-22 | 6-K | 2024-07-22 | REPORT OF FOREIGN PRIVATE ISSUER | ea0209792-6k_xtlbio.htm |
| 2024-06-12 | 6-K | 2024-06-11 | REPORT OF FOREIGN PRIVATE ISSUER | ea0207646-6k_xtlbio.htm |
| 2024-06-05 | 6-K | 2024-06-05 | REPORT OF FOREIGN PRIVATE ISSUER | ea0207353-6k_xtlbio.htm |
| 2024-05-13 | 6-K | 2024-05-13 | REPORT OF FOREIGN PRIVATE ISSUER | ea0205870-6k_xtlbiophar.htm |
| 2024-04-30 | 6-K | 2024-04-30 | REPORT OF FOREIGN PRIVATE ISSUER | ea0205014-6k_xtlbiophar.htm |
| 2024-04-02 | 6-K | 2024-04-02 | REPORT OF FOREIGN PRIVATE ISSUER | ea0203182-6k_xtlbio.htm |
| 2024-03-21 | 6-K/A | 2024-03-21 | AMENDMENT NO. 1 TO FORM 6-K | ea0202338-6ka1_xtlbio.htm |
| 2024-03-21 | 6-K | 2024-03-21 | REPORT OF FOREIGN PRIVATE ISSUER | ea0202214-6k_xtlbio.htm |
| 2024-03-20 | 6-K | 2024-03-20 | REPORT OF FOREIGN PRIVATE ISSUER | ea0202193-6k_xtlbiopharma.htm |